arrow
M

Matthias Schmid

University of Bonn
H指数:64
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Participatory development and feasibility study of a digital intervention for detecting and treating bio-psycho-social needs of long-term cancer survivors: study protocol of the DELPHIN study

参与式开发和对长期癌症幸存者生物-心理-社会需求进行检测与治疗的数字干预的可行性研究:DELPHIN研究的方案

2026-04-210
OA
Impact of Initial Prostate-Specific Membrane Antigen PET/CT Staging and Prostate-Specific Membrane Antigen-Targeted Biopsy on Treatment Decisions in Prostate Cancer: Results from the Phase 2 DEPROMP Trial

初始前列腺特异性膜抗原 PET/CT 分期和前列腺特异性膜抗原靶向活检对前列腺癌治疗决策的影响:DEPROMP II 期试验结果

2026-01-010
PRE
Improved Implementation of Tumor Board Decisions: A Retrospective Single Center Observational Study in Germany

改进肿瘤委员会决策的实施: 德国的一项回顾性单中心观察性研究

IN VIVO
IF1.8
2025-11-010
PRE
Patient-reported vision impairment in low luminance relates to visual function in age-related macular degeneration: A MACUSTAR study report

低亮度下患者报告的视力障碍与年龄相关性黄斑变性患者的视功能有关:MACUSTAR研究报告

2025-10-090
OA
“The DESCRIBE-ALS-FTD study: a prospective multicenter observational study of the ALS-FTD spectrum”

“DESCRIBE-ALS-FTD研究:一项关于ALS-FTD谱的 prospective multicenter observational study”

2025-06-090
OA
Non-genetic factors associated with ACE-inhibitor and angiotensin receptor blocker-induced angioedema

与ACE抑制剂和血管紧张素受体阻滞剂诱导的血管性水肿相关的非遗传因素

2025-05-070
OA
The ATLAS/NOA-29 study protocol: a phase III randomized controlled trial of anterior temporal lobectomy versus gross-total resection in newly-diagnosed temporal lobe glioblastoma

ATLAS/NOA-29研究方案: 一项新诊断的颞叶胶质母细胞瘤前颞叶切除术与全切除术的III期随机对照试验

2025-02-200
OAAI